Phase I Pilot Study Eval Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy

Trial ID or NCT#

NCT02058550

Status

not recruiting iconNOT RECRUITING

Purpose

This randomized, pilot phase I trial studies whether phone or email reminders increases vaginal dilator use in patients with endometrial, cervical, or vaginal cancers after they undergo brachytherapy. Brachytherapy is a type of internal radiation which uses radioactive material placed directly into or near a tumor to kill tumor cells. A reminder program may help increase use of vaginal dilators and decrease long-term side effects following brachytherapy.

Official Title

Phase I Pilot Study Evaluating Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy

Eligibility Criteria

Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No

Investigator(s)

Elizabeth Kidd
Elizabeth Kidd
Radiation oncologist
Professor of Radiation Oncology (Radiation Therapy)

Contact us to find out if this trial is right for you.

Contact

Dylann Fujimoto
650-723-8843